ASBP
Aspire Biopharma·NASDAQ
--
--(--)
--
--(--)
7.58 / 10
Outperform
Sentiment is supportive, with a fund flow score of 7.58/10 and consistently positive trends across all liquidity bands (small to extra-large). This robust capital inflow, coupled with a neutral analyst stance (no active coverage), highlights market confidence that could aid price stability despite technical and fundamental headwinds.
Fund Flow Rating
Is money flowing into or out of ASBP?
- ASBP holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.58/10 (Outperform).
